SCHEMBL7085989

SCHEMBL7085989

NC(=O)Cc1ccccc1Cl.O=C(O)c1nc(-n2ncc(=O)[nH]c2=O)ccc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 11/20 0.46
ABCB11 O95342 1/20 0.46
HSD17B10 Q99714 2/20 0.39
MEN1 O00255 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPT P10636 2/20 0.35
CREBBP Q92793 1/20 0.35
CLK1 P49759 1/20 0.34
CDK9 P50750 1/20 0.34
CDK5 Q00535 1/20 0.34
DYRK1A Q13627 1/20 0.34
DYRK2 Q92630 1/20 0.34
CLK4 Q9HAZ1 1/20 0.34
DYRK1B Q9Y463 1/20 0.34
THRB P10828 2/20 0.33
ALDH1A1 P00352 1/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7085991 0.88 P2RX7 (0.50) P2RX7ABCB11HSD17B10MEN1CYP2C9
SCHEMBL1412956 0.85 MEN1 (0.50) P2RX7ABCB11HSD17B10MEN1CYP2C9
SCHEMBL1413075 0.78 P2RX7 (0.67) P2RX7ABCB11MEN1KMT2AMAPT
SCHEMBL9823277 0.74 P2RX7 (0.42) P2RX7ABCB11MEN1KMT2AMAPT
SCHEMBL1412983 0.73 P2RX7 (0.48) P2RX7ABCB11
SCHEMBL1413007 0.71 P2RX7 (0.39) P2RX7HSD17B10MEN1CYP2C9CYP2C19
SCHEMBL1412941 0.70 P2RX7 (0.54) P2RX7ABCB11
SCHEMBL1091961 0.67 PKM (0.64) KMT2AMAPTALDH1A1LMNA
SCHEMBL9823746 0.67 P2RX7 (0.44) P2RX7ABCB11MEN1KMT2ATHRB
SCHEMBL6250130 0.67 ALDH1A1 (0.51) P2RX7ABCB11MEN1KMT2ATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030186981-A1 Benzamide, heteroarylamide and reverse amides PFIZER INC. 2003-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030186981-A1 Benzamide, heteroarylamide and reverse amides P2RX7, P2RX5, P2RX2 P2RX7 1/4885ABCB11 866/4885HSD17B10 4199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.